•Human neonatal heart-derived MSC-like stem cells with superior regenerative abilities when compared to other cell types in heart attack inflammatory models.
•Immortalized clonal isolate from human neonatal heart-derived MSC-like stem cells that can be expanded in very large numbers in-vitro with no loss of its phenotype and functionality and can be used to produce therapeutic secretome (NeosomePLUS™.)
•Cell-free enriched purified secretome (exosomes and secreted cytokines) from Neo3002™.
•Donor-independent standardized secretome product as an off-the-shelf cell-free therapeutic.
•Can be produced in unlimited quantities with no loss of phenotypic identity and in vivo efficacy.
•Has powerful anti-inflammatory, immunomodulatory, anti-fibrotic, and anti-apoptotic effects in-vitro and in-vivo.
•Is in process of being GMP-grade manufactured.